ANALYSIS OF GENETIC MUTATION PROFILE AND CNS PHARMACOKINETICS IN RELAPSED/REFRACTORY PRIMARY CNS LYMPHOMA PATIENTS RESPONDING TO NOVEL EMAVUSERTIB (IRAK4I) AND BTKI COMBINATION

Imbruvica (ibrutinib) - AbbVie, J&J

emavusertib (CA-4948) - Curis, Dr. Reddy’s

https://library.ehaweb.org/eha/2025/eha2025-congress/4162354/christian.grommes.analysis.of.genetic.mutation.profile.and.cns.html?f=menu%3D6%2Abrowseby%3D8%2Asortby%3D2%2Amedia%3D3%2Ace_id%3D2882%2Aot_id%3D31553%2Amarker%3D5845%2Afeatured%3D19595

Christian Grommes; Anna Dabrowska-Iwanicka; Han Tun; Christopher D'Angelo; Adolfo De La Fuente; Itai Levi; Lakshmi Nayak; David Lavie; Alessia Castellino; Michał Taszner; Praveen Ramakrishnan Geethkumar; Laurence Schenone; Andrés Ferreri; Teresa Calimeri; Luca Nassi; Caroline Houillier; Anna Schmitt; Gaurav Choudhary; Wanying Zhao; Grzegorz S. Nowakowski

May 16, 2025